Improving access to HIV prevention medication in Louisiana using health data
Leveraging Local Health System Electronic Health Record Data to Enhance PrEP Access in Southeastern Louisiana: A Community-Informed Approach
This study is working to make it easier for people in Southeastern Louisiana to get HIV prevention medication called PrEP by using technology to find those at risk and connect them with healthcare providers who can help.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11138597 on NIH RePORTER |
What this research studies
This research aims to enhance access to pre-exposure prophylaxis (PrEP) for HIV prevention in Southeastern Louisiana by utilizing electronic health record (EHR) data. The project will implement machine learning algorithms to identify individuals at risk for HIV and notify them through community outreach. Additionally, it will alert healthcare providers in emergency and urgent care settings about patients who may benefit from PrEP during their visits. By integrating these strategies, the research seeks to bridge the gap between healthcare systems and community needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals in Southeastern Louisiana who are at high risk for HIV infection and may benefit from PrEP.
Not a fit: Patients who are not at risk for HIV or those who are already receiving PrEP may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of individuals receiving PrEP, thereby reducing HIV transmission rates in the community.
How similar studies have performed: Previous research has shown promise in using EHR data and machine learning for identifying at-risk populations, but this specific approach in a Southern healthcare context is novel.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Okeke, Nwora Lance — Duke University
- Study coordinator: Okeke, Nwora Lance
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.